Elevated VEGF-B levels contribute significantly to renal lipotoxicity in DKD, whereas pharmacological inhibition of VEGF-B signaling reduces renal lipid accumulation and alleviates DKD [163]. The gene discussed is VEGFB; the disease is diabetic kidney disease.